|
kerlund, K; Erlandsson Harris, H; Tracey, K J et al. (1999) Anti-inflammatory effects of a new tumour necrosis factor-alpha (TNF-alpha) inhibitor (CNI-1493) in collagen-induced arthritis (CIA) in rats. Clin Exp Immunol 115:32-41
|
|
Molina, P E; Qian, L; Schuhlein, D et al. (1998) CNI-1493 attenuates hemodynamic and pro-inflammatory responses to LPS. Shock 10:329-34
|
|
Cohen, P S; Nakshatri, H; Dennis, J et al. (1996) CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. Proc Natl Acad Sci U S A 93:3967-71
|
|
Bianchi, M; Bloom, O; Raabe, T et al. (1996) Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med 183:927-36
|
|
Cockroft, K M; Meistrell 3rd, M; Zimmerman, G A et al. (1996) Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke 27:1393-8
|
|
Cerami, C; Zhang, X; Ulrich, P et al. (1996) High-performance liquid chromatographic method for guanylhydrazone compounds. J Chromatogr B Biomed Appl 675:71-5
|
|
Bianchi, M; Ulrich, P; Bloom, O et al. (1995) An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality. Mol Med 1:254-66
|
